-
公开(公告)号:CZ278593A3
公开(公告)日:1995-07-12
申请号:CZ278593
申请日:1993-12-16
Applicant: BASF AG
Inventor: STEINER GERD DR , UNGER LILIANE DR , BEHL BERTHOLD DR , TESCHENDORF HANS-JUERGEN DR
IPC: C07D209/02 , A61K31/40
-
公开(公告)号:DK0409048T3
公开(公告)日:1995-03-27
申请号:DK90113143
申请日:1990-07-10
Applicant: BASF AG
IPC: C07D277/20 , A61K31/44 , A61K31/445 , A61K31/495 , A61K31/505 , A61P25/00 , A61P43/00 , C07D277/38 , C07D277/40 , C07D277/42 , C07D277/46 , C07D417/00 , C07D417/06 , C07D417/12 , C07D417/14
-
公开(公告)号:DE4219973A1
公开(公告)日:1993-12-23
申请号:DE4219973
申请日:1992-06-19
Applicant: BASF AG
Inventor: UNGER LILIANE DR , BEHL BERTHOLD DR , TESCHENDORF HANS-JUERGEN DR
IPC: C07D401/04 , A61K31/40 , A61K31/403 , A61K31/4427 , A61K31/4433 , A61K31/4439 , A61K31/445 , A61P25/00 , A61P25/02 , A61P25/20 , A61P43/00 , C07D209/52 , C07D409/04 , C07D403/04
Abstract: Compounds having formula (I), in which the substituents have the meaning given in the description, are disclosed, as well as their preparation. These new compounds are useful for treating diseases.
-
公开(公告)号:DE3882589D1
公开(公告)日:1993-09-02
申请号:DE3882589
申请日:1988-05-13
Applicant: BASF AG
Inventor: STEINER GERD DR , PFISTER JUERGEN DR , TESCHENDORF HANS-JUERGEN DR , UNGER LILIANE DR , BINDER RUDOLF DR
Abstract: 4-Amino-10-cyanomethylene -pyrrolo (3,4-c) benz(b)azepine derivs. of formula (I) and their acid-addn. salts are new: In (I), R1 = H, halogen, 1-3C alkyl, CF3 or 1-3C alkoxy; R2 and R3 = H or halogen; R4 = H, 1-3C alkyl, or aryl (1-3C) alkyl opt. ring-substd. by halogen, 1-3C alkyl or OMe; A = NR3R6 or NHR7; NR5R6 is a satd. 5- to 7-membered ring opt. contg. O, NR or NR-O; R = H, 1-3C alkyl, 2-3C hydroxyalkyl, 2-3C alkoxyalkyl, 3-7C cycloalkyl, (3-7C cycloalkyl)methyl or 2-5C alkynyl; R7 = 2-7C aminoalkyl in which the amine N is opt. substd. by a 1-5C alkyl gp. or forms part of a satd. 5- to 7-membered ring opt. contg. O or NR"; R" = H, 1-3C alkyl or 2-3C hydroxyalkyl. 10-Cyanomethylene-4- (4-methyl-1-piperazinyl)- pyrrolo (3,4-c) benz(b)azepine and its 7-chloro deriv. are specifically claimed.
-
25.
公开(公告)号:AT29720T
公开(公告)日:1987-10-15
申请号:AT83111339
申请日:1983-11-12
Applicant: BASF AG
Inventor: SCHLECKER RAINER DR , SCHMIDT PETER DR , THIEME PETER C DR , LENKE DIETER PROF DR , TESCHENDORF HANS-JUERGEN DR , TRAUT MARTIN DR , MUELLER CLAUS D DR , HOFMANN HANS PETER DR , KREISKOTT HORST PROF DR
IPC: A61K31/35 , A61K31/352 , A61K31/365 , A61K31/37 , A61P25/18 , A61P25/24 , A61P25/26 , A61P37/08 , A61P43/00 , C07D311/08 , C07D311/16 , C07D311/78 , C07D311/80
-
公开(公告)号:AT13885T
公开(公告)日:1985-07-15
申请号:AT81110719
申请日:1981-12-23
Applicant: BASF AG
Inventor: THIEME PETER C DR , STEINER GERD DR , ROHR WOLFGANG DR , LENKE DIETER DR , GRIES JOSEF DR , WEIFENBACH HARALD DR , TESCHENDORF HANS-JUERGEN DR , HOFMANN HANS PETER DR , KREISKOTT HORST DR
IPC: C07D249/08 , A61K31/41 , A61K31/415 , A61K31/495 , A61K31/496 , A61P9/02 , A61P11/00 , A61P25/20 , C07D231/12 , C07D233/60 , C07D233/61 , C07D271/10 , C07D295/06 , C07D295/067 , C07D295/096 , C07D521/00
-
27.
公开(公告)号:DE3163823D1
公开(公告)日:1984-07-05
申请号:DE3163823
申请日:1981-03-11
Applicant: BASF AG
Inventor: MAY HANS-JOACHIM DR , LENKE DIETER DR , GRIES JOSEF DR , TESCHENDORF HANS-JUERGEN DR , WORSTMANN WOLFGANG DR
IPC: C07D409/06 , A61K31/33 , A61K31/415 , A61K31/465 , A61K31/47 , A61P9/08 , A61P9/10 , A61P9/12 , A61P43/00 , C07D233/54 , C07D233/64 , C07D401/06 , C07D403/06 , C07D405/06 , C07D413/06 , C07D417/06
Abstract: 1-Aroyl-2-phenylamino-2-imidazolines of the general formula where R1 and R2 are identical or different and each is chlorine, bromine, fluorine, methyl, ethyl, methoxy, trifluoromethyl or cyano, R3 has the meanings given for R1 and R2 or is hydrogen and Ar is an unsubstituted or substituted monocyclic or bicyclic heteroaromatic radical containing 1, 2 or 3 nitrogen and/or oxygen and/or sulfur atoms, their salts with physiologically tolerated acids, their preparation, and drugs containing these compounds. The compounds have, inter alia, a blood pressure-reducing action.
-
公开(公告)号:DE19747063A1
公开(公告)日:1999-04-29
申请号:DE19747063
申请日:1997-10-24
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , DULLWEBER UTA DR , STARCK DOROTHEA DR , STEINER GERD DR , BACH ALFRED DR , EMLING FRANZ DR , GARCIA-LADONA FRANCISCO JAVIER , TESCHENDORF HANS-JUERGEN DR , WICKE KARSTEN DR
IPC: A61K31/519 , A61P1/00 , A61P1/14 , A61P3/04 , A61P5/00 , A61P9/12 , A61P15/00 , A61P25/00 , A61P25/22 , A61P25/24 , A61P25/28 , A61P43/00 , C07D471/00 , C07D471/04 , A61K31/505
Abstract: 3-Substituted tetrahydropyridopyrimidinone derivatives (I) and their acid salts are new. 3-Substituted tetrahydropyridopyrimidinone derivatives of formula (I) and their acid salts are new. One of X and Y = CH2 and the other = NR ; R = H, 1-6C alkyl, (1-4C alkyl)carbonyl, CO2-tert.-butyl, arylcarbonyl or phenyl-(1-4C alkyl), which may itself be ring-substituted by F, Cl, Br, I, 1-4C alkyl, 1-4C alkoxy, CF3, OH, NH2, CN or NO2; A = 1-10C alkylene or 2-10C alkylene containing one or more Z groups; Z = O, S, NR , cyclopropyl, CO2, CHOH, or a double or triple bond; R = H or 1-4C alkyl; B' = 4-piperidine, 4-(1,2,3,6-tetrahydropyridine), 4-piperazine or one of these rings N-bound to A via a methylene group; Ar = phenyl (optionally substituted by 1-6C alkyl, 1-6C alkoxy, OH, F, Cl, Br, I, CF3, N(R )2, CO2R , CN or phenyl), tetralinyl, indanyl, other condensed aromatic moieties e.g. naphthalinyl (optionally substituted by 1-4C alkyl or 1-4C alkoxy), anthracenyl, or a 5- or 6-membered aromatic heterocycle with 1 or 2 O or N heteroatoms, which can be anellated with other aromatic groups.
-
公开(公告)号:DE19746612A1
公开(公告)日:1999-04-29
申请号:DE19746612
申请日:1997-10-22
Applicant: BASF AG
Inventor: LUBISCH WILFRIED DR , DULLWEBER UTA DR , STARCK DOROTHEA DR , STEINER GERD DR , BACH ALFRED DR , EMLING FRANZ DR , GARCIA-LADONA FRANCISCO JAVIER , TESCHENDORF HANS-JUERGEN DR , WIECKE KARSTEN DR
IPC: A61K31/428 , A61P25/24 , A61P43/00 , C07D275/06 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , A61K31/445 , A61K31/44 , A61K31/425
Abstract: 2-Substituted 1,2-benzisothiazole derivatives (I) and their acid salts are new. 2-Substituted 1,2-benzisothiazole derivatives of formula (I) and their enantiomers, diastereomers, tautomers and acid salts are new. R , R = independently 1-6C alkyl; R , R = independently H, 1-6C alkyl, OH, 1-6C alkoxy, F, Cl, Br, I, CF3, NR R , CO2R , NO2, CN, pyrrolo, or phenyl-(1-4C alkyl), which may itself be ring-substituted by F, Cl, Br, I, 1-4C alkyl, 1-4C alkoxy, CF3, OH, NH2, CN or NO2; R , R = independently H, 1-6C alkyl, benzoyl, CO2-tert.-butyl, (1-4C alkyl)carbonyl or together form a 5- or 6-membered ring, which may contain a second N atom (e.g. piperazinyl); R = H or 1-6C alkyl; A = 1-10C alkylene or 2-10C alkylene containing one or more Z groups; Z = O, S, NR , cyclopropyl, CHOH, or a double or triple bond; B = 4-piperidine, 4-(1,2,3,6-tetrahydropyridine), 4-piperazine or one of these rings N-bound to A via a methylene group; Ar = phenyl (optionally substituted by 1-6C alkyl, 1-6C alkoxy, OH, F, Cl, Br, I, CF3, NR R , CO2R , CN or phenyl), tetralinyl, indanyl, other condensed aromatic moieties e.g. naphthalinyl (optionally substituted by 1-4C alkyl or 1-4C alkoxy), anthracenyl, or a 5- or 6-membered aromatic heterocycle with 1 or 2 O or N heteroatoms, which can be anellated with other aromatic groups.
-
公开(公告)号:DE19728996A1
公开(公告)日:1999-01-14
申请号:DE19728996
申请日:1997-07-07
Applicant: BASF AG
Inventor: STARCK DOROTHEA DR , BLANK STEFAN DR , TREIBER HANS-JOERG DR , UNGER LILIANE DR , NEUMANN-SCHULTZ BARBARA DR , LE BRIS THEOPHILE-MARIE , TESCHENDORF HANS-JUERGEN DR , WICKE KARSTEN DR
IPC: A61K31/33 , A61K31/41 , A61K31/4196 , A61K31/454 , A61K31/506 , A61K31/53 , A61K31/551 , A61P25/00 , A61P25/16 , A61P25/18 , A61P25/22 , A61P25/24 , A61P43/00 , C07D249/08 , C07D249/12 , C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D409/14 , C07D413/14 , C07D417/14 , C07D403/10
Abstract: The present invention relates to triazole compounds of formula (I), wherein Ar , A, B and Ar have the meanings cited in the description. The inventive compounds exhibit high dopamine-D3-receptor affinity and can thus be used in the treatment of diseases responding to dopamine-D3-ligands.
-
-
-
-
-
-
-
-
-